TREATMENT FOR EAR DISCHARGE USING KUSHTADI TAILA AND CIPROFLOXACIN EAR DROPS

OPEN LABEL CLINICAL STUDY TO COMPARE THE EFFECT OF KUSHTADI TAILA PICHU AND CIPROFLOXACIN EAR DROPS IN PUTIKARNA ? ( safe chronic suppurative otitis media )

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021197

Enrollment

Registered

2019-09-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H661- Chronic tubotympanic suppurative otitis media

Interventions

Intervention1: KUSHTADI TAILA: Taila used as Karna pichu Route of administration - ear Dose 3ml Frequency daily twice kept for one hour Duration for 7days Control Intervention1: CIPROFLOXACIN EAR DR

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with features of Safe Chronic Suppurative Otitis media for more than 3 months. 2.Patients in the age group of 6 to 40 year and irrespective of gender.

Exclusion criteria

Exclusion criteria: 1. Ear discharge associated with complications such as cholesteatoma, polyps, granulation tissue, and purulent discharge with foul smell. 2. Patients with immune compromised diseases. 3. Pregnant and lactating women. 4. Attic and total perforations. 5. Patients with severe conductive deafness, mixed deafness. 6. Patients with blood stained ear discharge.

Design outcomes

Primary

Measure	Time frame
Absence of dischargeTimepoint: 7DAYS	—

Secondary

Measure	Time frame
complete absence of ear discharge and Improvement in the lifestyle and health of the patientTimepoint: 14 DAYS	—

Countries

India

Contacts

Public ContactDR RAJU S N

SHRI JAGADGURU GVISIDDESHWARA AYURVEDIC MEDICAL COLLEGE

drveerurh@yahoo.co.in9448544376

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026